Intervention to Enhance PrEP Persistence for Black/African American Men
This study is testing a behavioral intervention called RAMP-It-Up Initiation, Adherence, and Retention Intervention. This intervention uses facilitated strengths-based case management to help Black/African American men who have sex with men (MSM) navigate the healthcare system and overcome challenges in getting PrEP (pre-exposure prophylaxis), a daily medication that dramatically reduces the risk of getting HIV. The study wants to see if this intervention helps people start and continue taking PrEP. You may be able to join if you are an HIV-negative Black/African American man, aged 18 or older, who has had male sex partners in the past year, and has not taken PrEP for at least 30 days. The study will measure how well participants take PrEP by looking at pharmacy records and drug levels in their bodies at 3 and 12 months.
- Study design
- This is an interventional study with a planned enrollment of 300 participants. It is a randomized controlled trial (RCT).
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months, with measurements taken at 3 and 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Intervention to Enhance PrEP Persistence
At a glance
Conditions
Where it's being run
3 sites across 3 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- PrEP Adherence - Pharmacy Fill Data3 and 12 Month Follow Ups
The primary outcome will be PrEP adherence, given adherence is the definitive marker associated with protection from HIV infection. Adherence will be measured using pharmacy fill data in order to determine whether participants have picked up their prescription on a monthly basis.
- PrEP Adherence - Drug Levels3 and 12 Month Follow Ups
The primary outcome will be PrEP adherence, given adherence is the definitive marker associated with protection from HIV infection. Adherence will be assessed by dried blood spot sampling for PrEP drug levels.